𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Zotepine in the prevention of recurrence: a randomised, double-blind, placebo-controlled study for chronic schizophrenia

✍ Scribed by S.J. Cooper; A. Butler; J. Tweed; C. Welch; J. Raniwalla

Publisher
Springer
Year
2000
Tongue
English
Weight
196 KB
Volume
150
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A randomised, double-blind, placebo-cont
A randomised, double-blind, placebo-controlled, 5-weeks' study of org 3770 (mirtazapine) in major depression
✍ M. C. Khan πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 433 KB

Fifty-four hospitalised and outpatients with a DSM 111 diagnosis of major depressive disorder and 21-item HPRSD score of 2 18, were randomised to 5 weeks' of treatment with either Org 3770 (n=27; 20-60mg/day) or placebo (n = 27). The treatment with Org 3770 resulted in statistically significant and

Mirtazapine add-on therapy in the treatm
Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial
✍ Michael Berk; Clarissa S. Gama; Suresh Sundram; Harry Hustig; Les Koopowitz; Rus πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 78 KB πŸ‘ 1 views

## Abstract ## Objective Schizophrenia is a multifaceted illness with positive, negative and cognitive symptom domains. Standard treatments often focus on positive symptoms and may not adequately relieve other symptoms. Previous studies have suggested a role for mirtazapine in schizophrenia, parti

Norfloxacin prevents spontaneous bacteri
Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: Results of a double-blind, placebo-controlled trial
✍ Dr. Pere GinΓ©s; Antoni Rimola; RamΓ³n Planas; Victor Vargas; Francesc Marco; Manu πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 958 KB

Eighty cirrhotic patients who had recovered from an episode of spontaneous bacterial peritonitis were included in a multicenter, double-blind trial aimed at comparing long-term norfloxacin administration (400 mglday; 40 patients) vs. placebo (40 patients) in the prevention of spontaneous bacterial p